San Diego’s Persephone Biosciences, a startup working on cancer therapies and precision probiotics based on the gut microbiome, has landed $15 million in early stage seed […]
An artificial intelligence-driven device that works to detect and predict hemodynamic instability may provide a more accurate picture of patient deterioration than traditional vital sign measurements, […]
Nonalcoholic fatty liver disease (NAFLD) is well recognized as a leading cause of chronic liver disease, affecting more than 25 percent of the U.S. and global […]